0001062993-23-011404.txt : 20230517 0001062993-23-011404.hdr.sgml : 20230517 20230517163319 ACCESSION NUMBER: 0001062993-23-011404 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carr Douglas CENTRAL INDEX KEY: 0001867173 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40498 FILM NUMBER: 23932254 MAIL ADDRESS: STREET 1: C/O CENTURY THERAPEUTICS, INC. STREET 2: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Century Therapeutics, Inc. CENTRAL INDEX KEY: 0001850119 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842040295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25 N 38TH STREET, 11TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 215-981-4000 MAIL ADDRESS: STREET 1: 25 N 38TH STREET, 11TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-05-15 0001850119 Century Therapeutics, Inc. IPSC 0001867173 Carr Douglas 3675 MARKET STREET PHILADELPHIA PA 19104 0 1 0 0 SVP Finance & Operations 0 Common Stock 2023-05-15 4 A 0 120846 0 A 321391 D Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the "Company's") common stock. The RSUs shall vest 50% on November 1, 2023, with the remaining 50% vesting upon the earlier of: (i) November 1, 2024; and (ii) satisfaction of certain performance criteria, in each case subject to the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. /s/ Michael Diem, Attorney-in-Fact 2023-05-17